ROQAF (Roquefort Therapeutics) Operating Cash Flow per Share : $-0.01 (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Roquefort Therapeutics Operating Cash Flow per Share?

Roquefort Therapeutics's operating cash flow per share for the six months ended in Dec. 2024 was $-0.00. Roquefort Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Roquefort Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

ROQAF's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.2
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Roquefort Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Roquefort Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Operating Cash Flow per Share Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

-0.02

-0.01

Roquefort Therapeutics Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial			-0.03	-0.01	-0.01	-0.01	-

Competitive Comparison of Roquefort Therapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Roquefort Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roquefort Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roquefort Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Roquefort Therapeutics's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Roquefort Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Roquefort Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-0.991	/	130.034
	=	-0.01

Roquefort Therapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-0.327	/	130.918
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.01

Roquefort Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (OTCPK:ROQAF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ROQ:UK

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. Its product portfolio consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical next-generation medicines focused on hard-to-treat cancers.

Roquefort Therapeutics Headlines

From GuruFocus

Roquefort Therapeutics PLC at OTC Markets Life Science Investor Forum (Virtual) Transcript

By GuruFocus Research • 03-27-2024